摘要
目的:探讨妇科恶性肿瘤化疗后骨髓抑制与患者生存质量的相关性,以期找到治疗护理的最佳方法,提高临床治疗效果。方法:选取2015年6月~2016年6月来我院就诊的妇科恶性肿瘤化疗患者78例为研究对象,观察患者骨髓抑制发生情况与患者生存质量的相关性。结果:78例妇科恶性肿瘤患者化疗后,根据骨髓的造血功能骨髓抑制分级表得出骨髓抑制组42例和未发生骨髓抑制组36例,再根据生存质量量表评分比较发现两组生活能力和健康状况均有明显下降(P<0.05);得出妇科恶性肿瘤化疗后骨髓抑制与患者生存质量的存在相关关系。结论:妇科恶性肿瘤化疗后会发生骨髓抑制和患者生存质量下降,两者存在相关关系。
Objective： To discuss the correlation between marrow suppression and patients＇ survival quality after chemotherapy of gynecological malignant tumor,so as to find out the best method for the treatment and nursing and improve the clinical treatment effect. Methods： Selected 78 patients receiving chemotherapy of gynecological malignant tumor in our hospital from June 2015 to June 2016,and the patients were observed in the correlation between marrow suppression and patients＇ survival quality. Results： After the 78 patients with gynecological malignant tumor received chemotherapy,according to the hematopoietic function of marrow,in the marrow suppression rating table,42 patients were included in the marrow suppression group and 36 patients were included in the group without marrow suppression,and then through comparison according to the survival quality scale,it was found that the living ability and health condition of patients in both groups decreased significantly（ P〈0. 05）,and it was concluded that after chemotherapy of gynecological malignant tumor,there was a correlation between the marrow suppression and the patients＇ survival quality. Conclusion： After chemotherapy of gynecological malignant tumor,marrow suppression would occur,and the patients＇ survival quality would decrease,with a correlation between the two.
出处
《护理实践与研究》
2017年第17期82-83,共2页
Nursing Practice and Research
关键词
妇科恶性肿瘤
化疗
骨髓抑制
生存质量
相关性
Gynecological malignant tumor
Chemotherapy
Marrow suppression
Quality of life
Correlation
